NCT01067222 Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy Status COMPLETED Phase PHASE3
NCT01006122 A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy Status COMPLETED Phase PHASE2
NCT00916253 Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies Status COMPLETED Phase NA
NCT00484757 Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition Status UNKNOWN Phase NA
NCT00424931 A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy Status COMPLETED Phase PHASE2
NCT00366080 Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy Status TERMINATED Phase PHASE2
NCT00244465 Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription Status COMPLETED Phase N/A
NCT00228566 Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome Status COMPLETED Phase PHASE3
NCT00228553 Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness Status COMPLETED Phase PHASE3
NCT00214968 Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness Status COMPLETED Phase PHASE3
NCT00132873 Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy Status COMPLETED Phase PHASE3
NCT00107848 PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome Status COMPLETED Phase PHASE3
NCT00107796 Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy Status COMPLETED Phase PHASE3
NCT00078377 Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy Status COMPLETED Phase PHASE3
NCT00078312 Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder Status COMPLETED Phase PHASE3
NCT00066170 Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy Status COMPLETED Phase PHASE3
NCT00049803 Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients Status COMPLETED Phase PHASE3
NCT00001664 Sleep Disorders of Patients With Diseases of the Nervous System Status COMPLETED Phase N/A